… Treatment with monoclonal antibody combinations limits generation of SARSCoV-2 escape
variants in humans and model animals and protects against current variants of concern. …

… trial, REGEN-COV, a combination of the monoclonal antibodies casirivimab and … COV
has activity in vitro against current severe acute respiratory syndrome coronavirus 2 (SARS-CoV…

… ongoing exposure to a person infected with SARS-CoV-2. We used a household-contact
trial design to assess whether REGEN-COV could prevent SARS-CoV-2 infection in a scenario …

… of neutralizing antibodies. Here we describe several monoclonal antibodies that target the S
glycoprotein of SARS-CoV-2, … Antibody cocktails that include S309 in combination with other …

… SARS-CoV infection by subneutralizing antibody concentrations is of concern, we show here
that anti-SARS-CoV antibodies … human macrophages by SARS-CoV into a productive one. …

… antiviral potency and can prevent the emergence of antibody escape mutations (Hansen et
al.… benefit of antibody combinations for in vivo protection, we tested mixtures of antibodies that …

… on the SARS-CoV-2 spike protein receptor binding domain and block virus entry. The two-antibody
combination reduces the risk of emergence of treatment-induced SARS-CoV-2 …

… Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely
used in … REGEN-COV antibody combination and outcomes in outpatients with COVID-19. …

… Antibody cocktails represent a promising approach to prevent SARS-CoV-2 escape. The
determinants for selecting antibody combinations and the mechanism that antibody cocktails …

… for the loss of SARS-CoV-2 neutralization by the antibodies, we generated VSV-SARS-CoV-2
spike … Two or more anti-SARS-CoV-2 spike RBD antibody combination can strengthen …